ArticleOncotarget2017

Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.

Wei-Qun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.